SG153840A1 - Novel compound having inhibitory effect on lipase - Google Patents

Novel compound having inhibitory effect on lipase

Info

Publication number
SG153840A1
SG153840A1 SG200904245-8A SG2009042458A SG153840A1 SG 153840 A1 SG153840 A1 SG 153840A1 SG 2009042458 A SG2009042458 A SG 2009042458A SG 153840 A1 SG153840 A1 SG 153840A1
Authority
SG
Singapore
Prior art keywords
compound
novel
lipase
beverages
foods
Prior art date
Application number
SG200904245-8A
Other languages
English (en)
Inventor
Masaaki Nakai
Yuko Fukui
Sumio Asami
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of SG153840A1 publication Critical patent/SG153840A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
    • A23F5/243—Liquid, semi-liquid or non-dried semi-solid coffee extract preparations; Coffee gels; Liquid coffee in solid capsules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Tea And Coffee (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG200904245-8A 2004-06-21 2005-06-20 Novel compound having inhibitory effect on lipase SG153840A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004182471A JP5475938B2 (ja) 2004-06-21 2004-06-21 リパーゼ阻害活性を有する新規化合物

Publications (1)

Publication Number Publication Date
SG153840A1 true SG153840A1 (en) 2009-07-29

Family

ID=35509613

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200904245-8A SG153840A1 (en) 2004-06-21 2005-06-20 Novel compound having inhibitory effect on lipase

Country Status (10)

Country Link
US (2) US20110118344A1 (zh)
EP (1) EP1783127B1 (zh)
JP (1) JP5475938B2 (zh)
KR (1) KR101342288B1 (zh)
CN (1) CN101094851B (zh)
ES (1) ES2571131T3 (zh)
HK (1) HK1108889A1 (zh)
SG (1) SG153840A1 (zh)
TW (1) TWI385166B (zh)
WO (1) WO2005123725A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9028886B2 (en) * 2007-07-13 2015-05-12 Ogawa & Co., Ltd. Degradation inhibitor for flavor or aroma
JP5579789B2 (ja) * 2007-09-26 2014-08-27 サントリー食品インターナショナル株式会社 茶抽出物、茶飲料及びそれらの製造方法
JP5238993B2 (ja) * 2007-09-26 2013-07-17 サントリー食品インターナショナル株式会社 茶抽出物、茶飲料及びそれらの製造方法
JP5282340B2 (ja) * 2008-03-13 2013-09-04 長岡香料株式会社 天然素材の抗酸化作用および／またはリパーゼ阻害活性を増強させる方法、ならびに当該活性が増強された天然素材
WO2010073404A1 (ja) 2008-12-26 2010-07-01 株式会社ニチレイバイオサイエンス カシューアップルのプロアントシアニジン、プロアントシアニジン含有組成物、およびその用途
KR101991746B1 (ko) 2011-10-04 2019-06-25 (주)아모레퍼시픽 카테킨 생체 이용률 증진제
JP6998126B2 (ja) * 2016-04-22 2022-01-18 アルコム・ニッケイ・スペシャルティ・コーティングズ・エスデーエヌ・ビーエッチデー 有機親水性塗料組成物、及び親水性皮膜、並びに熱交換器用アルミニウム材
JP6967261B2 (ja) * 2017-03-01 2021-11-17 国立大学法人九州大学 メタボリックシンドロームの予防又は改善用食品組成物及び医薬組成物
JPWO2019044672A1 (ja) * 2017-08-28 2020-10-22 株式会社Ｎｂｃメッシュテック ポリフェノールの製造方法
KR101886802B1 (ko) 2017-12-18 2018-08-08 (주)아모레퍼시픽 카테킨 생체 이용률 증진제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03219872A (ja) * 1990-01-25 1991-09-27 Meiji Seika Kaisha Ltd リパーゼ阻害剤
JPH03228664A (ja) * 1990-02-02 1991-10-09 Meiji Seika Kaisha Ltd 脂質の消化吸収抑制機能を有する食品
JPH09322710A (ja) * 1996-06-03 1997-12-16 Minato Seiyaku Kk カテキン類を含有する茶抽出物の製造方法
JP4507027B2 (ja) * 1998-12-04 2010-07-21 明治乳業株式会社 Ｍｍｐ阻害剤

Also Published As

Publication number Publication date
WO2005123725A1 (ja) 2005-12-29
KR20070027710A (ko) 2007-03-09
WO2005123725A9 (ja) 2007-08-09
HK1108889A1 (en) 2008-05-23
TW200602343A (en) 2006-01-16
ES2571131T3 (es) 2016-05-24
TWI385166B (zh) 2013-02-11
JP5475938B2 (ja) 2014-04-16
EP1783127A4 (en) 2010-06-23
CN101094851B (zh) 2011-01-12
JP2006001909A (ja) 2006-01-05
CN101094851A (zh) 2007-12-26
US20120329862A1 (en) 2012-12-27
EP1783127B1 (en) 2016-03-30
US20110118344A1 (en) 2011-05-19
KR101342288B1 (ko) 2013-12-20
EP1783127A1 (en) 2007-05-09

Similar Documents

Publication Publication Date Title
SG153840A1 (en) Novel compound having inhibitory effect on lipase
Chu et al. Roasted coffees high in lipophilic antioxidants and chlorogenic acid lactones are more neuroprotective than green coffees
SG150510A1 (en) Lipase activity inhibitors containing high-molecular weight polyphenol fractions, tea extracts, and processes for producing the same
JP5498471B2 (ja) リパーゼ阻害剤
AU2010250330B2 (en) Anti-obesity agent comprising compound containing benzotropolone ring
WO2009081250A3 (en) Product tablet and related pack
EP1754702A4 (en) EPIGALLOCATECHIN DIMERS OR TRIMERS WITH LIPASE-HEMMENDER AND / OR ANTIOXIDATIVE EFFECT
WO2009011271A1 (ja) 香味又は香気の劣化抑制剤
WO2008155998A1 (ja) 抗不安抗うつ剤
NZ593710A (en) Flavor enhancing agent and flavoring composition
EP2540307A4 (en) ANTIBACTERIAL TOOL WITH A COMBU EXTRACT AS AN ACTIVE, ANTIBACTERIAL COMPOSITION AND FOOD OR BEVERAGE THEREWITH
RU2016107746A (ru) Средство, способствующее абсорбции гидрокситирозола и его производных in vivo, и применение такого средства
Dias et al. Compositional variation among black tea across geographies and their potential influence on endothelial nitric oxide and antioxidant activity
JP2007151467A (ja) エピガロカテキンガレートの吸収性改善方法、これを用いた飲食品及び飲食品用素材、これらの製造方法
WO2010090498A3 (ko) 이고들빼기 추출물, 이의 분획물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 간 기능 개선용 약학적 조성물 및 간 기능 개선용 건강기능 식품조성물
Akram et al. Antioxidant potential of black tea (Camellia sinensis L.)-A review
EP1770090A4 (en) TEA POLYPHENOL COMPOSITION AND CORRESPONDING PRODUCTION PROCESS
US20120263849A1 (en) Bitterness suppression method
WO2007002854A3 (en) Inducing peripheral blood vessel vasodilation
JP2004315409A5 (zh)
WO2011046411A3 (ko) 뇌신경 세포 보호 활성 및 아세틸콜린에스테라제 저해 활성을 갖는 율피 추출물 및 그의 용도
WO2009048128A1 (ja) 体重増加抑制剤
WO2006108430A8 (en) Nutrient composition comprising green tea polyphenols for treating osteosarcoma
WO2009142458A3 (ko) 벌개미취 추출물, 벌개미취 분획물, 이로부터 분리한 짐나스테르코리아인 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 발암 예방용 건강기능성 식품 조성물
Wang et al. Effect of solvent type on antioxidant activities and protective capacity on HUVEC cells from damage induced by Na2S2O3 of Jiuqu Hongmei tea extracts